Ramaswamy Vivek's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Sep 5, 2025
- Accession no.
- 0002007997-25-000007
- Filed
- Sep 5, 2025
- Trade date
- Sep 3-5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $22.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ramaswamy VivekCIK 0001635075 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Common Shares | SSaleDisposed | −1,195,000 | $12.50 | −$14,937,500 | 36,089,108 | Direct | |
| Sep 4, 2025 | Common Shares | SSaleDisposed | −194,933 | $12.92 | −$2,518,534.36 | 35,894,175 | Direct | |
| Sep 5, 2025 | Common Shares | SSaleDisposed | −385,816 | $12.96 | −$5,000,175.36 | 35,508,359 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.